OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
September 01, 2016
Flexible batch sizes for semi-continuous unit operations, such as tableting and encapsulation, can improve efficiency while maintaining quality.
Sound process understanding and having effective controls in place are crucial in ensuring that consistent product quality is obtained during API manufacturing.
One of the major challenges in working with excipients today is understanding, and adjusting to, complexity in materials and formulations.
A study demonstrates the feasibility of a novel solid-dose formulation injection technology to effectively deliver a therapeutic treatment without the aid of a needle.
IPEC consultant Irwin Silverstein discusses third-party audits and regulatory compliance issues facing suppliers and their customers.
Innovative technologies and services meet needs for existing and emerging biologic-based therapies.
Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.
The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms.
Click the title above to open the Pharmaceutical Technology 2016 APIs, Excipients, and Manufacturing Supplement in an interactive PDF format.